Kinase Chemodiversity from the Arctic: The Breitfussins

Area of Science:

• Marine Natural Products
• Medicinal Chemistry
• Chemical Biology

Background:

• The indole-oxazole-pyrrole framework is present in the breitfussin family of natural products.
• Marine organisms are a source of novel chemical entities with therapeutic potential.

Purpose of the Study:

• To isolate and characterize new halogenated breitfussins from *Thuiaria breitfussi*.
• To evaluate the potential of breitfussins as kinase inhibitors for cancer therapy.

Main Methods:

• Isolation and structural elucidation of six new halogenated breitfussins (compounds 3-8).
• Confirmation of structures via total synthesis.
• In vitro evaluation of cytotoxicity against cancer cell lines.
• Kinase inhibition assays against panels of protein kinases.
• Assessment of ATP-competitive binding and in vitro ADME parameters.

Main Results:

• Two breitfussins (3 and 4) selectively inhibited cancer cell lines, with compound 3 showing potent activity (IC50 = 340 nM) against triple-negative breast cancer (MDA-MB-468).
• Compound 3 demonstrated potent inhibition of PIM1 (IC50 = 200 nM) and DRAK1 (IC50 = 390 nM) kinases via ATP-competitive binding.
• Initial toxicological and ADME profiling of compound 3 indicated favorable properties for further drug development.

Conclusions:

• The breitfussin scaffold is a promising starting point for the development of selective kinase inhibitors.
• Breitfussins exhibit potent anticancer activity and specific kinase inhibition, warranting further investigation as therapeutic agents.